{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:43:32Z","timestamp":1786974212373,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Public Health Service"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24-CA76518"],"award-info":[{"award-number":["U24-CA76518"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung and Blood Institute (NHLBI)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"crossref","award":["5U01HL069294"],"award-info":[{"award-number":["5U01HL069294"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NCI"},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-06-1-0704"],"award-info":[{"award-number":["N00014-06-1-0704"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-08-1-0058"],"award-info":[{"award-number":["N00014-08-1-0058"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006329","name":"AABB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Allos, Inc."},{"DOI":"10.13039\/100002429","name":"Amgen, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Anonymous donation to the Medical College of Wisconsin"},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001738","name":"Be the Match Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001738","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Biovitrum AB"},{"name":"BloodCenter of Wisconsin"},{"DOI":"10.13039\/100007501","name":"Blue Cross and Blue Shield Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007501","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bone Marrow Foundation"},{"DOI":"10.13039\/100001480","name":"The Bailey Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006432","name":"Terumo BCT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006432","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002815","name":"CellGenix","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002815","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children's Leukemia Research Association"},{"name":"ClinImmune Labs"},{"name":"CTI Clinical Trial and Consulting Services"},{"name":"Eisai, Inc."},{"DOI":"10.13039\/100004328","name":"Genentech, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Genzyme Corporation"},{"name":"Histogenetics, Inc."},{"name":"HKS Medical Information Systems"},{"name":"Hospira, Inc."},{"name":"Kirin Brewery Co., Ltd."},{"DOI":"10.13039\/100005189","name":"The Leukemia & Lymphoma Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Merck & Company"},{"name":"The Medical College of Wisconsin"},{"name":"Millennium Pharmaceuticals, Inc."},{"name":"Miller Pharmacal Group"},{"name":"Milliman USA, Inc."},{"name":"Miltenyi Biotec, Inc."},{"name":"National Marrow Donor Program"},{"name":"Nature Publishing Group"},{"name":"Novartis Oncology"},{"DOI":"10.13039\/100005462","name":"Oncology Nursing Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007075","name":"Osiris Therapeutics, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007075","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009155","name":"Otsuka America Pharmaceutical, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009155","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pall Life Sciences"},{"name":"Pfizer Inc"},{"name":"Schering Corporation"},{"DOI":"10.13039\/100009996","name":"Sigma-Tau Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009996","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Soligenix, Inc."},{"name":"StemCyte, Inc."},{"name":"StemSoft Software, Inc."},{"name":"Sysmex America, Inc."},{"DOI":"10.13039\/100004361","name":"Texas Instruments Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004361","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vidacare Corporation"},{"name":"ViraCor Laboratories"},{"name":"ViroPharma, Inc."},{"DOI":"10.13039\/100004382","name":"WellPoint, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bbmt.2014.07.021","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T16:05:28Z","timestamp":1406131528000},"page":"1819-1827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hospital Length of Stay in the First 100\u00a0Days after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft Sources"],"prefix":"10.1016","volume":"20","author":[{"given":"Karen K.","family":"Ballen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud D.","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6rg\u00fcn","family":"Akpek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haydar A.","family":"Frangoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar O.","family":"Freytes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"LeMaistre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Szwajcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celalettin","family":"Ustun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet S.","family":"Majhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.07.021_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2014.07.021_bib2","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.07.021_bib3","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia","volume":"351","author":"Rocha","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.07.021_bib4","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1182\/blood-2006-04-020172","volume":"109","author":"Takahashi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.021_bib5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.bbmt.2013.06.006","article-title":"Similar overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia","volume":"19","author":"Peffault de Latour","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbmt.2011.10.016","article-title":"Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts","volume":"18","author":"Chen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib7","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(07)60915-5","article-title":"Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study","volume":"369","author":"Eapen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2014.07.021_bib8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood-2012-05-426783","article-title":"Economics of hematopoietic cell transplantation","volume":"120","author":"Khera","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.021_bib9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.bbmt.2012.04.001","article-title":"Costs and cost-effectiveness of hematopoietic cell transplantation","volume":"18","author":"Preussler","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/bmt.2012.133","article-title":"Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2009.01.011","article-title":"Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pbc.22250","article-title":"Costs of pediatric allogeneic hematopoietic cell transplantation","volume":"54","author":"Majhail","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2014.07.021_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbmt.2010.08.017","article-title":"Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants","volume":"17","author":"Solh","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib14","unstructured":"Pasquini M, Wang Z. Current use and outcome of hematopoietic stem cell transplantation. CIBMTR summary slides, 2013. Available from: http:\/\/www.cibmtr.org. Accessed March 1, 2014."},{"key":"10.1016\/j.bbmt.2014.07.021_bib15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.bbmt.2009.07.023","article-title":"Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation","volume":"15","author":"Baker","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bbmt.2011.10.040","article-title":"Relationship of race\/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes","volume":"18","author":"Ballen","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib17","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2014.07.021_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbmt.2007.10.010","article-title":"Costs of allogeneic hematopoietic cell transplantation with high-dose regimens","volume":"14","author":"Saito","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bmt.1705733","article-title":"Lower costs associated with hematopoietic cell transplantation using reduced-intensity vs high-dose regimens for hematological malignancy","volume":"40","author":"Saito","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib22","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1097\/01.TP.0000129409.84087.62","article-title":"Predicting the costs of allogeneic sibling stem cell transplantation: results from a prospective, multicenter French study","volume":"77","author":"Esperou","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2014.07.021_bib23","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.transproceed.2008.06.086","article-title":"Evaluation of readmission in children receiving allogeneic hematopoietic stem cell transplantation: an institutional experience","volume":"40","author":"Jaing","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2014.07.021_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1703641","article-title":"Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia","volume":"30","author":"van Agthoven","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib25","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00277-012-1530-2","article-title":"Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study","volume":"91","author":"Blommestein","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2014.07.021_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3324\/haematol.2013.092254","article-title":"Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France","volume":"99","author":"Labopin","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2014.07.021_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.021_bib28","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/bmt.2011.214","article-title":"Racial disparities in hematopoietic cell transplantation in the United States","volume":"47","author":"Majhail","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib29","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbmt.2009.12.529","article-title":"Access to hematopoietic cell transplantation in the United States","volume":"16","author":"Majhail","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib30","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.bbmt.2010.08.011","article-title":"Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities","volume":"16","author":"Barker","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib31","series-title":"Health, United States, 2011: with special feature on socioeconomic status and health","author":"National Center for Health Statistics","year":"2012"},{"key":"10.1016\/j.bbmt.2014.07.021_bib32","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2004-10-3863","article-title":"Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States","volume":"105","author":"Loberiza","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.07.021_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbmt.2011.03.008","article-title":"Allogeneic transplant physician and center capacity in the United States","volume":"17","author":"Majhail","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.07.021_bib34","first-page":"43","article-title":"The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type","volume":"16","author":"Allen","year":"2013","journal-title":"J\u00a0Med Econ"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114004479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114004479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:48:42Z","timestamp":1761058122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114004479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1083879114004479"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.07.021","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospital Length of Stay in the First 100\u00a0Days after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia in Remission: Comparison among Alternative Graft Sources","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}